Search Results 141-150 of 16589 for liraglutide

  1. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Side effects & uses - Mayo Clinic

    Rituximab and hyaluronidase human, recombinant combination injection is used alone or together with other cancer medicines to treat follicular lymphoma and ...

  2. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    The purpose of this long-term data collection of patients with benign or malignant hematologic diseases is to collect patient demographics, disease ...

  3. https://www.mayoclinic.org/arabic_patient_consumer_recipe.xml

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Etranacogene dezaparvovec-drlb (intravenous route) - Side effects & uses - Mayo Clinic

    Etranacogene dezaparvovec-drlb injection is used to treat hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have ...

  7. Side effects of cholinesterase inhibitors can include nausea, diarrhea, loss of bladder control, muscle cramps, muscle twitching and weight loss. If taken at ...

  8. Clinical trials - Oncology (Medical)

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  9. Lefamulin (intravenous route) - Mayo Clinic

    Description. Lefamulin injection is used to treat community-acquired bacterial pneumonia (CABP). Lefamulin belongs to the class of medicines known as ...

  10. Taselisib And Enzalutamide In Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...